Novo CEO pressed by Senate to cut selling prices of obesity, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the company would contemplate new talks with insurers concerning the record rates of Wegovy and copyright whenever they pledge to help keep the medicines on their own formularies. https://simonfxqia.azzablog.com/30776870/considerations-to-know-about-healthcare-news